With only 70 months left to meet the SDGs, the world faces a stark reality in the fight against AIDS, requiring urgent action ...

As many as 600,000 people could die over the next 10 years in South Africa alone as a result of U.S. funding cuts, study says ...

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

Hundreds of HIV doctors and researchers have called on the Trump administration to reverse its sweeping aid funding cuts, ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

Without public health surveillance, officials trying to tackle outbreaks, identify threats and evaluate treatments are working ‘in the darkness of ignorance.’ ...

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

In the wake of US funding cuts for global aid, numerous donor-funded health facilities in South Africa have shut down and ...

Federal datasets began disappearing from public view on Jan 31, in response to executive orders from President Donald Trump.